Screening for HIV-Associated Anal Cancer
TRACE
TRACE
Sponsor study identifier
Secondary identifiers
OTHER_GRANT · CANFAR
observational
401
1 country
1
Study Start
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2012
Actual (reported)Study Completion
June 2012
Actual (reported)Cancer of the anus occurs at very high rates in young men with HIV and is caused by a virus called human papillomavirus (HPV). Anal cancer has increased during the HIV epidemic despite effective therapies for HIV. Unfortunately, anal cancer presents at a late stage because there is no screening program to find it at an early stage. Rates of other cancers such as cervical cancer have been reduced through the use of Pap smears. The researchers' plan is to do the same type of screening for anal cancer as has been done for cervical cancer. If abnormalities are found then treatment can be started. The researchers hope that this approach will help to prevent anal cancer. Testing for HPV will also be done to see if this helps to detect early cancer and to see how accurate different tests, pathologists and clinical examiners are at detecting and agreeing on any abnormalities. The main outcome is the presence of any pre-cancerous or early cancer changes as determined by high resolution anoscopy (HRA). HRA involves looking through a microscope into the anus and this allows very tiny changes to be identified. Pieces of tissue can then be taken to make a definite diagnosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 9, 2005
Actual (reported)September 16, 2005
Actual (reported)June 2012
Actual (reported)June 2012
Actual (reported)Those who had histologic anal high-grade disease.
Those who had less than highgrade histologic anal disease
HIV + MSM who had High Resolution Anoscopy
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Irving E Salit, MD
Toronto General Hospital
401 participants (actual enrollment reported by the registry).
First Submitted
September 9, 2005
First Posted
September 16, 2005
Study Start
August 2002
Date type not reportedThis date has not been verified as actual or estimated.
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
Contact the study team to confirm eligibility.
Primary Completion
June 2012
Actual (reported)Study Completion
June 2012
Actual (reported)Last Updated
March 8, 2016
Record last verified: 2016-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: